Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Feb 2011 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Motilal Oswal Nifty Midcap 100 ETF |
|---|---|
| 03 Feb 2011 | ₹100.00 |
| 21 May 2012 | ₹89.16 |
| 06 Sep 2013 | ₹89.49 |
| 23 Dec 2014 | ₹161.99 |
| 09 Apr 2016 | ₹170.31 |
| 26 Jul 2017 | ₹243.32 |
| 12 Nov 2018 | ₹229.95 |
| 28 Feb 2020 | ₹223.87 |
| 15 Jun 2021 | ₹364.52 |
| 01 Oct 2022 | ₹413.38 |
| 17 Jan 2024 | ₹639.19 |
| 04 May 2025 | ₹732.52 |
| 20 Aug 2026 | ₹875.04 |
| Metric | Motilal Oswal NAV ₹68.74 Very High risk ★★★★☆ | Category median Other ETFs · 248 funds |
|---|---|---|
| +10.46% | +3.65% | |
| +19.51% | +10.51% | |
| +19.27% | +9.28% | |
| +15.79% | +11.93% | |
| +14.98% | +10.38% | |
| +18.33% | — | |
| +17.98% | +14.30% | |
| +16.71% | +13.74% | |
| +16.33% | +12.83% | |
| Risk | ||
| 18.07% | 15.45% | |
| 0.72 | 0.28 | |
| 0.96 | 0.41 | |
| -48.39% | -20.59% | |
| Nifty Midcap 150 | — | |
| +1.00% | +0.80% | |
| 1.03 | 1.00 | |
| 106.1% | 102.1% | |
| 104.0% | 96.4% | |
| 0.28% | 0.32% | |
| ₹840.48Cr | ₹137.31Cr | |
| None | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Rakesh Shetty · 1.7y | — | |
| 03 Feb 2011 | — | |
| 100 | — | |
| 22.0% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.